48 related articles for article (PubMed ID: 10381335)
1. A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells.
Kume A; Ito K; Ueda Y; Hasegawa M; Urabe M; Mano H; Ozawa K
Biochem Biophys Res Commun; 1999 Jun; 260(1):9-12. PubMed ID: 10381335
[TBL] [Abstract][Full Text] [Related]
2. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells.
Xu R; Kume A; Matsuda KM; Ueda Y; Kodaira H; Ogasawara Y; Urabe M; Kato I; Hasegawa M; Ozawa K
J Gene Med; 1999; 1(4):236-44. PubMed ID: 10738556
[TBL] [Abstract][Full Text] [Related]
3. Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy.
Matsuda KM; Kume A; Ueda Y; Urabe M; Hasegawa M; Ozawa K
Gene Ther; 1999 Jun; 6(6):1038-44. PubMed ID: 10455406
[TBL] [Abstract][Full Text] [Related]
4. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch.
Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674
[TBL] [Abstract][Full Text] [Related]
5. Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells.
Ito K; Ueda Y; Kokubun M; Urabe M; Inaba T; Mano H; Hamada H; Kitamura T; Mizoguchi H; Sakata T; Hasegawa M; Ozawa K
Blood; 1997 Nov; 90(10):3884-92. PubMed ID: 9354655
[TBL] [Abstract][Full Text] [Related]
6. Expansion of genetically corrected neutrophils in chronic granulomatous disease mice by cotransferring a therapeutic gene and a selective amplifier gene.
Hara T; Kume A; Hanazono Y; Mizukami H; Okada T; Tsurumi H; Moriwaki H; Ueda Y; Hasegawa M; Ozawa K
Gene Ther; 2004 Sep; 11(18):1370-7. PubMed ID: 15229634
[TBL] [Abstract][Full Text] [Related]
7. In vivo selective expansion of gene-modified hematopoietic cells in a nonhuman primate model.
Hanazono Y; Nagashima T; Takatoku M; Shibata H; Ageyama N; Asano T; Ueda Y; Dunbar CE; Kume A; Terao K; Hasegawa M; Ozawa K
Gene Ther; 2002 Aug; 9(16):1055-64. PubMed ID: 12140733
[TBL] [Abstract][Full Text] [Related]
8. Selective expansion of genetically modified T cells using an antibody/interleukin-2 receptor chimera.
Sogo T; Kawahara M; Tsumoto K; Kumagai I; Ueda H; Nagamune T
J Immunol Methods; 2008 Aug; 337(1):16-23. PubMed ID: 18589435
[TBL] [Abstract][Full Text] [Related]
9. A coumermycin/novobiocin-regulated gene expression system.
Zhao HF; Boyd J; Jolicoeur N; Shen SH
Hum Gene Ther; 2003 Nov; 14(17):1619-29. PubMed ID: 14633404
[TBL] [Abstract][Full Text] [Related]
10. In vivo expansion of transduced murine hematopoietic cells with a selective amplifier gene.
Kume A; Koremoto M; Xu R; Okada T; Mizukami H; Hanazono Y; Hasegawa M; Ozawa K
J Gene Med; 2003 Mar; 5(3):175-81. PubMed ID: 12666183
[TBL] [Abstract][Full Text] [Related]
11. The Bmx tyrosine kinase is activated by IL-3 and G-CSF in a PI-3K dependent manner.
Ekman N; Arighi E; Rajantie I; Saharinen P; Ristimäki A; Silvennoinen O; Alitalo K
Oncogene; 2000 Aug; 19(36):4151-8. PubMed ID: 10962576
[TBL] [Abstract][Full Text] [Related]
12. Selection and growth regulation of genetically modified cells with hapten-specific antibody/receptor tyrosine kinase chimera.
Tanaka K; Kawahara M; Ueda H; Nagamune T
Biotechnol Prog; 2009; 25(4):1138-45. PubMed ID: 19569211
[TBL] [Abstract][Full Text] [Related]
13. Chimeric VEGFRs are activated by a small-molecule dimerizer and mediate downstream signalling cascades in endothelial cells.
Knight EL; Warner AJ; Maxwell A; Prigent SA
Oncogene; 2000 Nov; 19(47):5398-405. PubMed ID: 11103941
[TBL] [Abstract][Full Text] [Related]
14. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor.
Yuan X; Cong Y; Hao J; Shan Y; Zhao Z; Wang S; Chen J
J Mol Biol; 2004 May; 339(1):131-44. PubMed ID: 15123426
[TBL] [Abstract][Full Text] [Related]
15. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
Stagg J; Wu JH; Bouganim N; Galipeau J
Cancer Res; 2004 Dec; 64(24):8795-9. PubMed ID: 15604233
[TBL] [Abstract][Full Text] [Related]
17. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
Gormley NA; Orphanides G; Meyer A; Cullis PM; Maxwell A
Biochemistry; 1996 Apr; 35(15):5083-92. PubMed ID: 8664301
[TBL] [Abstract][Full Text] [Related]
18. GyrB mutations in Staphylococcus aureus strains resistant to cyclothialidine, coumermycin, and novobiocin.
Stieger M; Angehrn P; Wohlgensinger B; Gmünder H
Antimicrob Agents Chemother; 1996 Apr; 40(4):1060-2. PubMed ID: 8849232
[TBL] [Abstract][Full Text] [Related]
19. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
20. Proteolytic cleavage of granulocyte colony-stimulating factor and its receptor by neutrophil elastase induces growth inhibition and decreased cell surface expression of the granulocyte colony-stimulating factor receptor.
Hunter MG; Druhan LJ; Massullo PR; Avalos BR
Am J Hematol; 2003 Nov; 74(3):149-55. PubMed ID: 14587040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
